Potential role of sodium-proton exchangers in the low concentration arsenic trioxide-increased intracellular pH and cell proliferation

PLoS One. 2012;7(12):e51451. doi: 10.1371/journal.pone.0051451. Epub 2012 Dec 6.

Abstract

Arsenic main inorganic compound is arsenic trioxide (ATO) presented in solution mainly as arsenite. ATO increases intracellular pH (pHi), cell proliferation and tumor growth. Sodium-proton exchangers (NHEs) modulate the pHi, with NHE1 playing significant roles. Whether ATO-increased cell proliferation results from altered NHEs expression and activity is unknown. We hypothesize that ATO increases cell proliferation by altering pHi due to increased NHEs-like transport activity. Madin-Darby canine kidney (MDCK) cells grown in 5 mmol/L D-glucose-containing DMEM were exposed to ATO (0.05, 0.5 or 5 µmol/L, 0-48 hours) in the absence or presence of 5-N,N-hexamethylene amiloride (HMA, 5-100 µmol/L, NHEs inhibitor), PD-98059 (30 µmol/L, MAPK1/2 inhibitor), Gö6976 (10 µmol/L, PKCα, βI and μ inhibitor), or Schering 28080 (10 µmol/L, H(+)/K(+)ATPase inhibitor) plus concanamycin (0.1 µmol/L, V type ATPases inhibitor). Incorporation of [(3)H]thymidine was used to estimate cell proliferation, and counting cells with a hemocytometer to determine the cell number. The pHi was measured by fluorometry in 2,7-bicarboxyethyl-5,6-carboxyfluorescein loaded cells. The Na(+)-dependent HMA-sensitive NHEs-like mediated proton transport kinetics, NHE1 protein abundance in the total, cytoplasm and plasma membrane protein fractions, and phosphorylated and total p42/44 mitogen-activated protein kinases (p42/44(mapk)) were also determined. Lowest ATO (0.05 µmol/L, ~0.01 ppm) used in this study increased cell proliferation, pHi, NHEs-like transport and plasma membrane NHE1 protein abundance, effects blocked by HMA, PD-98059 or Gö6976. Cell-buffering capacity did not change by ATO. The results show that a low ATO concentration increases MDCK cells proliferation by NHEs (probably NHE1)-like transport dependent-increased pHi requiring p42/44(mapk) and PKCα, βI and/or μ activity. This finding could be crucial in diseases where uncontrolled cell growth occurs, such as tumor growth, and in circumstances where ATO, likely arsenite, is available at the drinking-water at these levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiloride / analogs & derivatives
  • Analysis of Variance
  • Animals
  • Arsenic Trioxide
  • Arsenicals / metabolism*
  • Arsenicals / pharmacology
  • Blotting, Western
  • Carbazoles
  • Cell Count
  • Cell Fractionation
  • Cell Proliferation / drug effects*
  • Dogs
  • Flavonoids
  • Fluorometry
  • Hydrogen-Ion Concentration
  • Imidazoles
  • Macrolides
  • Madin Darby Canine Kidney Cells
  • Oxides / metabolism*
  • Oxides / pharmacology
  • Sodium-Hydrogen Exchangers / metabolism*

Substances

  • Arsenicals
  • Carbazoles
  • Flavonoids
  • Imidazoles
  • Macrolides
  • Oxides
  • Sodium-Hydrogen Exchangers
  • Sch 28080
  • Go 6976
  • 5-(N,N-hexamethylene)amiloride
  • Amiloride
  • concanamycin A
  • Arsenic Trioxide
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one

Grants and funding

This research was supported by Dirección de Investigación [DI-1339-07] and Vicerrectoría Académica, Universidad de Antofagasta (Chile), Fondo Nacional de Desarrollo Científico y Tecnológico [FONDECYT 1110977, 11110059, 3130583], Programa de Investigación Interdisciplinario (PIA) from Comisión Nacional de Investigación en Ciencia y Tecnología (CONICYT) [Anillos ACT-73] (Chile) and CONICYT Ayuda de Tesis [CONICYT AT-24120944]. CA and EG-G hold CONICYT-PhD (Chile) fellowships. FP was the recipient of a postdoctoral position (CONICYT PIA Anillos ACT-73 postdoctoral research associate at CMPL, Pontificia Universidad Católica de Chile). MC is a PhD student at Universidad de Antofagasta (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.